Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04635228 · ClinicalTrials.gov registry record
Biodesign® Otologic Repair Graft
A clinical trial, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- 87
- Enrollment target
NCT04635228 is a clinical trial that has completed, run by Cook Research Incorporated. The registered enrollment target is 87 participants.
The verdict
NCT04635228 has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The post-market follow-up clinical trial of the Cook® Biodesign® Otologic Repair Graft will follow patients up to 3 months post-implantation to determine the percent of patients with complete closure of the tympanic membrane.
Interventions
- DEVICE Biodesign Otologic Repair Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2025-12-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04635228
The ClinicalTrials.gov registry entry for NCT04635228 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biodesign Otologic Repair Graft is the first listed.
NCT04635228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04635228 about?
NCT04635228 is a clinical study titled "Biodesign® Otologic Repair Graft". The post-market follow-up clinical trial of the Cook® Biodesign® Otologic Repair Graft will follow patients up to 3 months post-implantation to determine the percent of patients with complete closure of the tympanic membrane.
What is the current status of trial NCT04635228?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2021-09-29. Estimated completion is 2025-12-23.
What interventions are being tested in trial NCT04635228?
The interventions under investigation include: Biodesign Otologic Repair Graft (DEVICE).
Who is sponsoring clinical trial NCT04635228?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.